Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors.

We report herein synthesis of PKCbeta-selective inhibitors possessing the novel pharmacophore of anilino-monoindolylmaleimide. Several compounds of this series exhibited IC50's as low as 50 nM against human PKCbeta2. One of the most potent compounds, 6l, inhibited PKCbeta1 and PKCbeta2 with IC50 of 21 and 5 nM, respectively, and exhibited selectivity of more than 60-fold in favor of PKCbeta2 relative to other PKC isozymes (PKCalpha, PKCgamma, and PKCepsilon).

[1]  M. Jirousek,et al.  Synthesis of bisindolylmaleimides using a palladium catalyzed cross-coupling reaction. , 1998, Bioorganic & medicinal chemistry letters.

[2]  C. Sergheraert,et al.  Design and synthesis of new leads for PKC bisubstrate inhibitors. , 1994 .

[3]  E. Eichler,et al.  Inhibitors of glycolic acid oxidase. 4-Substituted 3-hydroxy-1H-pyrrole-2,5-dione derivatives. , 1983, Journal of medicinal chemistry.

[4]  M. Faul,et al.  (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. , 1996, Journal of medicinal chemistry.

[5]  M. Jirousek,et al.  Protein kinase C inhibitors as novel anticancer drugs , 2001, Expert opinion on investigational drugs.

[6]  Claudia K Derian,et al.  Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3. , 2003, Bioorganic & medicinal chemistry letters.

[7]  M. Saunders,et al.  3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). , 2001, Bioorganic & medicinal chemistry letters.

[8]  M. Faul,et al.  Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta. , 2003, Bioorganic & medicinal chemistry letters.

[9]  J. Beijnen,et al.  Protein kinase C as a target for new anti-cancer agents , 1999 .

[10]  P. Davis,et al.  Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides. , 1992, Journal of medicinal chemistry.

[11]  P. Davis,et al.  Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. , 1992, Journal of medicinal chemistry.

[12]  R. Huber,et al.  Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential. , 1997, Structure.

[13]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[14]  Y. Kihara,et al.  [Role of protein kinase C isozymes in cellular functions and pathological conditions]. , 2002, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.